Display options
Cite
Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the Global Burden of Diseases Study 2019. Lancet HIV. 2021;8(10):e633-e651doi: 10.1016/S2352-3018(21)00152-1.
(2021). Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the Global Burden of Diseases Study 2019. The lancet. HIV, 8(10), e633-e651. https://doi.org/10.1016/S2352-3018(21)00152-1
"Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the Global Burden of Diseases Study 2019." The lancet. HIV vol. 8,10 (2021): e633-e651. doi: https://doi.org/10.1016/S2352-3018(21)00152-1
Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the Global Burden of Diseases Study 2019. Lancet HIV. 2021 Oct;8(10):e633-e651. doi: 10.1016/S2352-3018(21)00152-1. PMID: 34592142; PMCID: PMC8491452.
Copy Download .nbib Format: NLM
Share it on

Lancet HIV. 2021 Oct;8(10):e633-e651. doi: 10.1016/S2352-3018(21)00152-1.

Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the Global Burden of Diseases Study 2019.

The lancet. HIV

[No authors listed]

PMID: 34592142 PMCID: PMC8491452 DOI: 10.1016/S2352-3018(21)00152-1

Abstract

BACKGROUND: The sustainable development goals (SDGs) aim to end HIV/AIDS as a public health threat by 2030. Understanding the current state of the HIV epidemic and its change over time is essential to this effort. This study assesses the current sex-specific HIV burden in 204 countries and territories and measures progress in the control of the epidemic.

METHODS: To estimate age-specific and sex-specific trends in 48 of 204 countries, we extended the Estimation and Projection Package Age-Sex Model to also implement the spectrum paediatric model. We used this model in cases where age and sex specific HIV-seroprevalence surveys and antenatal care-clinic sentinel surveillance data were available. For the remaining 156 of 204 locations, we developed a cohort-incidence bias adjustment to derive incidence as a function of cause-of-death data from vital registration systems. The incidence was input to a custom Spectrum model. To assess progress, we measured the percentage change in incident cases and deaths between 2010 and 2019 (threshold >75% decline), the ratio of incident cases to number of people living with HIV (incidence-to-prevalence ratio threshold <0·03), and the ratio of incident cases to deaths (incidence-to-mortality ratio threshold <1·0).

FINDINGS: In 2019, there were 36·8 million (95% uncertainty interval [UI] 35·1-38·9) people living with HIV worldwide. There were 0·84 males (95% UI 0·78-0·91) per female living with HIV in 2019, 0·99 male infections (0·91-1·10) for every female infection, and 1·02 male deaths (0·95-1·10) per female death. Global progress in incident cases and deaths between 2010 and 2019 was driven by sub-Saharan Africa (with a 28·52% decrease in incident cases, 95% UI 19·58-35·43, and a 39·66% decrease in deaths, 36·49-42·36). Elsewhere, the incidence remained stable or increased, whereas deaths generally decreased. In 2019, the global incidence-to-prevalence ratio was 0·05 (95% UI 0·05-0·06) and the global incidence-to-mortality ratio was 1·94 (1·76-2·12). No regions met suggested thresholds for progress.

INTERPRETATION: Sub-Saharan Africa had both the highest HIV burden and the greatest progress between 1990 and 2019. The number of incident cases and deaths in males and females approached parity in 2019, although there remained more females with HIV than males with HIV. Globally, the HIV epidemic is far from the UNAIDS benchmarks on progress metrics.

FUNDING: The Bill & Melinda Gates Foundation, the National Institute of Mental Health of the US National Institutes of Health (NIH), and the National Institute on Aging of the NIH.

Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Conflict of interest statement

Declaration of interests S Afzal reports an unpaid leadership role as General Secretary for the Pakistan Society of Community Medicine and Public Health, working for prevention and advocacy of AIDS in

References

  1. AIDS. 2020 Jun 1;34(7):1047-1055 - PubMed
  2. PLoS Med. 2018 Jan 12;15(1):e1002489 - PubMed
  3. Curr Opin HIV AIDS. 2021 Jan;16(1):63-73 - PubMed
  4. AIDS. 2019 Dec 15;33 Suppl 3:S235-S244 - PubMed
  5. Science. 2013 Feb 22;339(6122):966-71 - PubMed
  6. J Virus Erad. 2016 Jul 01;2(3):156-61 - PubMed
  7. Nature. 2019 Jun;570(7760):189-193 - PubMed
  8. Lancet HIV. 2021 Feb;8(2):e106-e113 - PubMed
  9. Lancet. 2020 Oct 17;396(10258):1223-1249 - PubMed
  10. Trauma Violence Abuse. 2020 Oct;21(4):643-659 - PubMed
  11. AIDS Behav. 2017 Feb;21(2):331-334 - PubMed
  12. Curr Opin HIV AIDS. 2014 Mar;9(2):192-8 - PubMed
  13. AIDS Behav. 2020 Nov;24(11):3010-3013 - PubMed
  14. Curr Opin HIV AIDS. 2019 Sep;14(5):354-365 - PubMed
  15. Curr Opin HIV AIDS. 2019 Sep;14(5):381-386 - PubMed
  16. J Virus Erad. 2016 Nov 28;2(Suppl 4):7-14 - PubMed
  17. Lancet HIV. 2018 Nov;5(11):e667-e670 - PubMed
  18. Lancet. 2018 May 5;391(10132):1799-1829 - PubMed
  19. J Virus Erad. 2016 Nov 28;2(Suppl 4):1-6 - PubMed
  20. Lancet Infect Dis. 2016 Dec;16(12):1320-1322 - PubMed
  21. Lancet. 2020 Oct 17;396(10258):1160-1203 - PubMed
  22. PLoS One. 2013 Dec 18;8(12):e81355 - PubMed
  23. Lancet. 2016 Dec 10;388(10062):e19-e23 - PubMed
  24. Lancet. 2021 Mar 20;397(10279):1095-1106 - PubMed
  25. AIDS. 2010 Nov 13;24(17):2705-15 - PubMed
  26. PLoS Med. 2011 Feb 08;8(2):e1000414 - PubMed
  27. Lancet HIV. 2020 May;7(5):e308-e309 - PubMed
  28. Curr HIV/AIDS Rep. 2019 Aug;16(4):259-269 - PubMed
  29. Lancet HIV. 2019 Dec;6(12):e831-e859 - PubMed
  30. Curr Psychiatry Rep. 2019 Jun 3;21(7):47 - PubMed
  31. Open AIDS J. 2016 Apr 08;10:34-48 - PubMed
  32. Lancet Glob Health. 2020 Sep;8(9):e1132-e1141 - PubMed
  33. Lancet HIV. 2021 Jun;8(6):e363-e375 - PubMed
  34. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 May 10;41(5):662-666 - PubMed
  35. Curr Opin HIV AIDS. 2014 Mar;9(2):183-91 - PubMed
  36. Global Health. 2008 Sep 16;4:8 - PubMed
  37. AIDS. 2014 Nov;28 Suppl 4:S415-25 - PubMed
  38. Sociol Health Illn. 2011 May;33(4):522-39 - PubMed
  39. AIDS Care. 2020 May;32(sup2):47-56 - PubMed
  40. Clin Sci (Lond). 2016 Aug 1;130(16):1435-51 - PubMed
  41. AIDS. 2020 Jul 1;34(8):F1-F2 - PubMed
  42. PLoS Med. 2018 Oct 25;15(10):e1002678 - PubMed
  43. JAMA Netw Open. 2020 Jun 1;3(6):e207954 - PubMed
  44. Qual Health Res. 2011 May;21(5):587-600 - PubMed
  45. BMC Infect Dis. 2020 Oct 9;20(1):744 - PubMed
  46. Paediatr Int Child Health. 2017 May;37(2):99-108 - PubMed
  47. AIDS Behav. 2006 Jul;10(4):335-46; discussion 347-50 - PubMed
  48. AIDS. 2017 Apr;31 Suppl 1:S13-S22 - PubMed
  49. Lancet. 2020 Oct 17;396(10258):1204-1222 - PubMed

Publication Types

Grant support